Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing

Hong Kong Medical Journal

Volumn 15, Issue 5, 2009, Pages 326-331

  Lau, Gregory S K ^a   Lang, Brian H H ^a   Lo, C Y ^a   Tso, Annette ^a   Garcia Barcelo, Merce M ^a   Tam, Paul K ^a   Lam, Karen S L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Genetic screening; Multiple endocrine neoplasia type 2a; Proto oncogene proteins c ret; Thyroid neoplasms; Thyroidectomy

Indexed keywords

GENOMIC DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHILD; CHINESE; CLINICAL ARTICLE; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HONG KONG; HUMAN; HUMAN CELL; MALE; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SIPPLE SYNDROME; THYROID CARCINOMA; THYROID HYPERPLASIA; THYROID MEDULLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY; ULTRASOUND;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CALCITONIN; CALCIUM COMPOUNDS; CARCINOMA, MEDULLARY; CHILD; CHINA; FEMALE; FOLLOW-UP STUDIES; GENETIC TESTING; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; PROTO-ONCOGENE PROTEINS C-RET; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; VITAMIN D; YOUNG ADULT;

EID: 70350236903     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vasen HF, Nieuwenhuijzen Kruseman AC, Berkel H, et al. Multiple endocrine neoplasia syndrome type 2: the value of screening and central registration. A study of 15 kindreds in The Netherlands. Am J Med 1987;83:847-852 (Pubitemid 18098158)
2. Howe JR, Norton JA, Wells SA Jr. Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term followup. Surgery 1993;114:1070-1077
3. Skinner MA. Management of hereditary thyroid cancer in children. Surg Oncol 2003;12:101-104 (Pubitemid 37289015)
4. Danko ME, Skinner MA. Surgical intervention in children with multiple endocrine neoplasia type 2. Curr Opin Pediatr 2006;18:312-315 (Pubitemid 43832710)
5. Skinner MA, Moley JA, Diley WG, Owzar K, Debenedetti MK, Wells SA Jr. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 2005;353:1105-1113 (Pubitemid 41317433)
6. Kakudo K, Carney JA, Sizemore GW. Medullary carcinoma of thyroid. Biologic behavior of the sporadic and familial neoplasm. Cancer 1985;55:2818-2821
7. Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 1999;229:880-888
8. Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996;276:1575-1579 (Pubitemid 26314449)
9. Machens A, Ukkat J, Brauckhoff M, Gimm O, Dralle H. Advances in the management of hereditary medullary thyroid cancer. J Intern Med 2005;257:50-59 (Pubitemid 40129126)
10. Niccoli-Sire P, Murat A, Rohmer V, et al. Familial medullary thyroid carcinoma with noncysteine RET mutations: phenotype-genotype relationship in a large series of patients. J Clin Endocrinol Metab 2001;86:3746-3753 (Pubitemid 32755971)
11. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metabol 2001;86:5658-5671 (Pubitemid 33152604)
12. Piolat C, Dyon JF, Sturm N, et al. Very early prophylactic thyroid surgery for infants with a mutation of the RET proto-oncogene at codon 634: evaluation of the implementation of international guidelines for MEN type 2 in a single centre. Clin Endocrinol (Oxf) 2006;65:118-124 (Pubitemid 43911689)
13. Puñales MK, da Rocha AP, Meotti C, Gross JL, Maia AL. Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A. Thyroid 2008;18:1261-1268
14. Lo CY, Wat NM, Lam KY, Tiu SC, Chan J, Lam KS. Multiple endocrine neoplasia type 2A in Chinese families. Clin Endocrinol (Oxf) 2003;58:528. (Pubitemid 36390627)
15. Zhou Y, Zhao Y, Cui B, et al. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B. Clin Endocrinol (Oxf) 2007;67:570-576 (Pubitemid 47416316)
16. Ku CF, Lo CY, Chan WF, Chiu SW, Fan ST, Lam KS. Resection of phaeochromocytoma extending into the right atrium in a patient with multiple endocrine neoplasia type 2A. Hong Kong Med J 2005;11:59-62.
17. Sakorafas GH, Friess H, Peros G. The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy. Endocr Relat Cancer 2008;15:871-884
18. Graze K, Spiler IJ, Tashjian AH Jr, et al. Natural history of familial medullary thyroid carcinoma: effects of a program for early diagnosis. N Engl J Med 1978;299:980-985 (Pubitemid 9058043)
19. Learoyd DL, Marsh DJ, Richardson AL, Twigg SM, Delbridge L, Robinson BG. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. Arch Surg 1997;132:1022-1025
20. Wells SA Jr, Chi DD, Toshima K, et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994;220:237-250 (Pubitemid 24313219)
21. Lips CJ, Landsvater RM, Höppener JW, et al. Clinical screening as compared with DNA analysis in families with multiple endocrine type 2A. N Engl J Med 1994;331:828-835
22. Machens A, Holzhausen HJ, Dralle H. Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: systemic disease? Surgery 2006;139:28-32.
23. Bergenfelz A, Jansson S, Kristoffersson A, et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg 2008;393:667-673
24. Sanso GE, Domene HM, Garcia R, et al. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Cancer 2002;94:323-330 (Pubitemid 34081360)
25. Machens A, Niccoli-Sire P, Hoegel J, et al. Early malignant progression of hereditary meduallary thyroid cancer. N Engl J Med 2003;349:1517-1525 (Pubitemid 37255037)